Pain Syndromes and Management in Adult Hematopoietic Stem Cell Transplantation
作者： Joseph D. Ma , Areej R. El-Jawahri , Thomas W. LeBlanc , Eric J. Roeland
DOI: 10.1016/J.HOC.2018.01.012
关键词:
摘要: Pain is a significant physical symptom that can be observed across the spectrum of hematopoietic stem cell transplant (HSCT) care. assessment should include evaluation and functional components pain. Management varies based on type HSCT-specific pain syndrome. Future directions for management syndromes early integration palliative The purpose this review to summarize various approaches in adult HSCT patients.
sci-hub.se 参考文章(85)
Przepiorka D, Weisdorf D, Hows J, Beatty P, Martin P, Klingemann Hg, Thomas Ed, 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation. ,vol. 15, pp. 825- 828 ,(1995)
Philip J Wiffen, Sheena Derry, Rae Frances Bell, Andrew SC Rice, Thomas Rudolf Tölle, Tudor Phillips, R Andrew Moore, Gabapentin for chronic neuropathic pain in adults Cochrane Database of Systematic Reviews. ,vol. 6, pp. 0- 0 ,(2017) , 10.1002/14651858.CD007938.PUB4
Gerhard Heil, Dieter Hoelzer, Miguel A. Sanz, Klaus Lechner, John A. Liu Yin, Giuseppe Papa, Luc Noens, Jeff Szer, Arnold Ganser, Caroline O'Brien, James Matcham, Alan Barge, A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia Blood. ,vol. 90, pp. 4710- 4718 ,(1997) , 10.1182/BLOOD.V90.12.4710
Sheena Derry, Philip J Wiffen, Dominic Aldington, R Andrew Moore, Nortriptyline for neuropathic pain in adults Cochrane Database of Systematic Reviews. ,vol. 1, ,(2015) , 10.1002/14651858.CD011209.PUB2
Meletios A. Dimopoulos, Maria-Victoria Mateos, Paul G. Richardson, Rudolf Schlag, Nuriet K. Khuageva, Ofer Shpilberg, Martin Kropff, Ivan Spicka, Antonio Palumbo, Ka Lung Wu, Dixie-Lee Esseltine, Kevin Liu, William Deraedt, Andrew Cakana, Helgi Van De Velde, Jesús F. San Miguel, Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib–melphalan–prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study European Journal of Haematology. ,vol. 86, pp. 23- 31 ,(2011) , 10.1111/J.1600-0609.2010.01533.X
Gregory M. Cote, Ephraim P. Hochberg, Alona Muzikansky, Fred H. Hochberg, Jan Drappatz, Steven L. McAfee, Tracy T. Batchelor, Ann S. LaCasce, David C. Fisher, Jeremy S. Abramson, Philippe Armand, Yi-Bin Chen, Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma. Biology of Blood and Marrow Transplantation. ,vol. 18, pp. 76- 83 ,(2012) , 10.1016/J.BBMT.2011.07.006
Stephen T. Sonis, The pathobiology of mucositis. Nature Reviews Cancer. ,vol. 4, pp. 277- 284 ,(2004) , 10.1038/NRC1318
Stephen T. Sonis, Linda S. Elting, Dorothy Keefe, Douglas E. Peterson, Mark Schubert, Martin Hauer-Jensen, B. Nebiyou Bekele, Judith Raber-Durlacher, J. Peter Donnelly, Edward B. Rubenstein, , Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients Cancer. ,vol. 100, pp. 1995- 2025 ,(2004) , 10.1002/CNCR.20162
Masahiro Onozawa, Satoshi Hashino, Yoshifumi Haseyama, Yasuo Hirayama, Susumu Iizuka, Tadao Ishida, Makoto Kaneda, Hajime Kobayashi, Ryoji Kobayashi, Kyuhei Koda, Mitsutoshi Kurosawa, Nobuo Masauji, Takuya Matsunaga, Akio Mori, Masaya Mukai, Mitsufumi Nishio, Satoshi Noto, Shuichi Ota, Hajime Sakai, Nobuhiro Suzuki, Tohru Takahashi, Junji Tanaka, Yoshihiro Torimoto, Makoto Yoshida, Takashi Fukuhara, Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group. Biology of Blood and Marrow Transplantation. ,vol. 15, pp. 724- 729 ,(2009) , 10.1016/J.BBMT.2009.03.003
A Palumbo, S Bringhen, A Bertola, F Cavallo, P Falco, M Massaia, B Bruno, C Rus, A Barbui, T Caravita, P Musto, N Pescosta, F Rossini, M Vignetti, M Boccadoro, Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2)). Leukemia. ,vol. 18, pp. 133- 138 ,(2004) , 10.1038/SJ.LEU.2403196